Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02015338
Other study ID # 1311M45303
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 2014
Est. completion date December 2015

Study information

Verified date July 2019
Source University of Minnesota - Clinical and Translational Science Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Hypothesis: In typically developing children (TDC), use of conventional EEG landmarks to determine the brain area that controls hand function will not differ from TMS-guided determination of individual motor hotspots. In children with hemiparesis, however, those two locations will diverge. The prediction is that TMS will best guide Transcranial Direct Current Stimulation (tDCS) interventions


Description:

Congenital hemiparesis, mainly due to stroke, affects approximately 25% of children with cerebral palsy. Noninvasive brain stimulation has emerged to influence improvements in hand function specifically in children with congenital hemiparesis due to stroke.

The use of one type of noninvasive brain stimulation, Transcranial Direct Current Stimulation (tDCS), in conjunction with rehabilitation training intervention for a child with hemiparesis proposes a synergistic approach to improving hand function. Application of electrodes over certain targeted areas are placed with the intent to stimulate and influence neuronal activity.

Our preliminary evidence suggests that in children with hemiparesis due to stroke, the area for placement is variable as noted by electroencephalogram (EEG) and Transcranial Magnetic Stimulation (TMS) measurement methods, influencing the site location of optimal stimulation for tDCS.

Due to this variation, the optimal site of stimulation warrants investigation for the optimal placement of tDCS.


Recruitment information / eligibility

Status Completed
Enrollment 47
Est. completion date December 2015
Est. primary completion date September 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 8 Years to 17 Years
Eligibility Inclusion Criteria:

Typically Developing Children:

- Ages 8-17

Children with congenital hemiparesis due to hemispheric stroke:

- Ages 8-17

- Equal of greater than 10 degrees of active motion at the metacarpophalangeal joint

- No evidence of seizure activity within the last 2 years.

Exclusion Criteria:

Typically Developing Children:

- neurologic disorders

- indwelling metal

- pregnancy

- history of seizures

Children with hemiparesis:

- Metabolic disorders

- Neoplasm

- Epilepsy

- Disorders of cellular migration and proliferation

- Expressive aphasia

- Pregnancy

- Indwelling metal

- Botulinum toxin or phenol intramuscular block within the one-month preceding TMS application.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States University of Minnesota Minneapolis Minnesota

Sponsors (1)

Lead Sponsor Collaborator
University of Minnesota - Clinical and Translational Science Institute

Country where clinical trial is conducted

United States, 

References & Publications (2)

Rich TL, Menk JS, Rudser KD, Chen M, Meekins GD, Peña E, Feyma T, Bawroski K, Bush C, Gillick BT. Determining Electrode Placement for Transcranial Direct Current Stimulation: A Comparison of EEG- Versus TMS-Guided Methods. Clin EEG Neurosci. 2017 Nov;48(6):367-375. doi: 10.1177/1550059417709177. Epub 2017 May 22. — View Citation

Rich TL, Menk JS, Rudser KD, Feyma T, Gillick BT. Less-Affected Hand Function in Children With Hemiparetic Unilateral Cerebral Palsy: A Comparison Study With Typically Developing Peers. Neurorehabil Neural Repair. 2017 Oct-Nov;31(10-11):965-976. doi: 10.1177/1545968317739997. Epub 2017 Nov 12. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Determine the location of the motor cortex by two different means Determine the location of the motor cortex through two means: 1) The international 10/20 EEG system of measurement and 2) Transcranial Magnetic Stimulation (TMS) testing of cortical excitability in typically developing children and children with hemiparesis. 1 year
Secondary Measurement of distance in centimeters between the 10/20 EEG C3 or C4 location and the TMS-derived motor hotspot. Compare the two locations (in each hemisphere) determined by 10/20 EEG system and Transcranial Magnetic Stimulation (TMS) testing and measure in centimeters differences between the two locations. 1 year
See also
  Status Clinical Trial Phase
Completed NCT02091687 - Longitudinal Outcomes in Pediatric rTMS and CIT